Dicerna pushed up price and contacted other suitors before making deal with Novo Nordisk
![Photo: Valdemar Ren](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13499682.ece/ALTERNATES/schema-16_9/doc7ik8qbmy7nn1ejnodn3c.jpg)
When the hammer came down, Novo Nordisk's final bid for US-based Dicerna far exceeded its initial offer.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novo Nordisk acquires Dicerna for USD 3.3bn
For subscribers